Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
Nicole J. LeBlanc, MA
Contributor
Nicole J. LeBlanc is a doctoral candidate in clinical psychology at Harvard University, where she conducts research on the association between social factors and the development and maintenance of emotional disorders. She is also a clinical fellow in the department of psychology at Massachusetts General Hospital, where she is completing clinical and research training with the Cognitive Behavioral Therapy Program and the Center for Anxiety and Traumatic Stress Disorders. Her clinical interests include empirically-supported treatments for anxiety and traumatic stress disorders. She is a member of the Association for Behavioral and Cognitive Therapies (ABCT) and the Anxiety and Depression Association of America (ADAA).
Posts by Nicole J. LeBlanc, MA
Nicole J. LeBlanc, MA
Anxiety in college: What we know and how to cope
Healthy aging and longevity
How to handle stress at work
Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine